PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.42
Similar ESG score to EYEN's 60.91. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
57.61
Similar environmental score to EYEN's 58.54. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
61.21
Similar social score to EYEN's 62.27. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
62.44
Similar governance score to EYEN's 61.91. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.